APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance (PV) Outsourcing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmacovigilance (PV) Outsourcing Industry Growth and Trends Forecast to 2032

Report ID 174025270120 December 2025124 pages

Choose your research edition.

Industry ResearchPharmacovigilance (PV) Outsourcing Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance (PV) Outsourcing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance (PV) Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance (PV) Outsourcing Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance (PV) Outsourcing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmacovigilance (PV) Outsourcing market include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmacovigilance (PV) Outsourcing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmacovigilance (PV) Outsourcing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmacovigilance (PV) Outsourcing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmacovigilance (PV) Outsourcing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmacovigilance (PV) Outsourcing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmacovigilance (PV) Outsourcing Market by Company

Accenture

C3i Solutions

Clintec

Covance

Deloitte Touche Tohmatsu Limited

ELC Group

Ergomed

iGATE Corporation

iMED Global Corporation

IQVIA

MarksMan Healthcare

Medpace Holdings

Oracle Corporation

Parexel

PharmInvent

PrimeVigilance

Pure Drug Safety

Sciformix

SIRO Clinpharm

Symogen

Novartis

Pharmacovigilance (PV) Outsourcing Segment by Type

Contract Research Organizations (CROs)

Business Process Outsourcing (BPOs)

Pharmacovigilance (PV) Outsourcing Segment by Application

Premarketing Clinical Trial

Post-marketing Clinical Practice

Other

Pharmacovigilance (PV) Outsourcing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance (PV) Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance (PV) Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance (PV) Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2021-2026) Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2027-2032) Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2026) Table 9. Global Pharmacovigilance (PV) Outsourcing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmacovigilance (PV) Outsourcing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2026) Table 24. Global Pharmacovigilance (PV) Outsourcing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmacovigilance (PV) Outsourcing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmacovigilance (PV) Outsourcing Industry Trends Table 37. Pharmacovigilance (PV) Outsourcing Industry Drivers Table 38. Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges Table 39. Pharmacovigilance (PV) Outsourcing Industry Restraints Table 40. Global Pharmacovigilance (PV) Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company (2021-2026) Table 42. Global Pharmacovigilance (PV) Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmacovigilance (PV) Outsourcing Key Company Headquarters & Area Served Table 44. Global Pharmacovigilance (PV) Outsourcing Company, Product Type & Application Table 45. Global Pharmacovigilance (PV) Outsourcing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Accenture Company Information Table 49. Accenture Business Overview Table 50. Accenture Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio Table 52. Accenture Recent Development Table 53. C3i Solutions Company Information Table 54. C3i Solutions Business Overview Table 55. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio Table 57. C3i Solutions Recent Development Table 58. Clintec Company Information Table 59. Clintec Business Overview Table 60. Clintec Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio Table 62. Clintec Recent Development Table 63. Covance Company Information Table 64. Covance Business Overview Table 65. Covance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Covance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 67. Covance Recent Development Table 68. Deloitte Touche Tohmatsu Limited Company Information Table 69. Deloitte Touche Tohmatsu Limited Business Overview Table 70. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio Table 72. Deloitte Touche Tohmatsu Limited Recent Development Table 73. ELC Group Company Information Table 74. ELC Group Business Overview Table 75. ELC Group Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio Table 77. ELC Group Recent Development Table 78. Ergomed Company Information Table 79. Ergomed Business Overview Table 80. Ergomed Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio Table 82. Ergomed Recent Development Table 83. iGATE Corporation Company Information Table 84. iGATE Corporation Business Overview Table 85. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 87. iGATE Corporation Recent Development Table 88. iMED Global Corporation Company Information Table 89. iMED Global Corporation Business Overview Table 90. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 92. iMED Global Corporation Recent Development Table 93. IQVIA Company Information Table 94. IQVIA Business Overview Table 95. IQVIA Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio Table 97. IQVIA Recent Development Table 98. MarksMan Healthcare Company Information Table 99. MarksMan Healthcare Business Overview Table 100. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio Table 102. MarksMan Healthcare Recent Development Table 103. Medpace Holdings Company Information Table 104. Medpace Holdings Business Overview Table 105. Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio Table 107. Medpace Holdings Recent Development Table 108. Oracle Corporation Company Information Table 109. Oracle Corporation Business Overview Table 110. Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 112. Oracle Corporation Recent Development Table 113. Parexel Company Information Table 114. Parexel Business Overview Table 115. Parexel Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio Table 117. Parexel Recent Development Table 118. PharmInvent Company Information Table 119. PharmInvent Business Overview Table 120. PharmInvent Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio Table 122. PharmInvent Recent Development Table 123. PrimeVigilance Company Information Table 124. PrimeVigilance Business Overview Table 125. PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 127. PrimeVigilance Recent Development Table 128. Pure Drug Safety Company Information Table 129. Pure Drug Safety Business Overview Table 130. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio Table 132. Pure Drug Safety Recent Development Table 133. Sciformix Company Information Table 134. Sciformix Business Overview Table 135. Sciformix Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio Table 137. Sciformix Recent Development Table 138. SIRO Clinpharm Company Information Table 139. SIRO Clinpharm Business Overview Table 140. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio Table 142. SIRO Clinpharm Recent Development Table 143. Symogen Company Information Table 144. Symogen Business Overview Table 145. Symogen Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio Table 147. Symogen Recent Development Table 148. Novartis Company Information Table 149. Novartis Business Overview Table 150. Novartis Pharmacovigilance (PV) Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio Table 152. Novartis Recent Development Table 153. North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2026) Table 156. North America Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Pharmacovigilance (PV) Outsourcing Market Share Forecast by Country (2027-2032) Table 158. Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2026) Table 161. Europe Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Pharmacovigilance (PV) Outsourcing Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2026) Table 166. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share Forecast by Country (2027-2032) Table 168. Latin America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2026) Table 171. Latin America Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Pharmacovigilance (PV) Outsourcing Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2026) Table 176. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmacovigilance (PV) Outsourcing Product Image Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2021-2032) Figure 7. North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Contract Research Organizations (CROs) Image Figure 13. Global Contract Research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Business Process Outsourcing (BPOs) Image Figure 15. Global Business Process Outsourcing (BPOs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Pharmacovigilance (PV) Outsourcing Market Share by Type 2025 VS 2032 Figure 18. North America Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032) Figure 19. Europe Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032) Figure 21. Latin America Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032) Figure 23. Premarketing Clinical Trial Image Figure 24. Global Premarketing Clinical Trial Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Post-marketing Clinical Practice Image Figure 26. Global Post-marketing Clinical Practice Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pharmacovigilance (PV) Outsourcing Market Share by Application 2025 VS 2032 Figure 31. North America Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032) Figure 32. Europe Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032) Figure 34. Latin America Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Pharmacovigilance (PV) Outsourcing Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Pharmacovigilance (PV) Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Pharmacovigilance (PV) Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 41. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 44. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 47. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 50. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPOs)
Applications
  • Premarketing Clinical Trial
  • Post-marketing Clinical Practice
  • Other
Companies covered
  • Accenture
  • C3i Solutions
  • Clintec
  • Covance
  • Deloitte Touche Tohmatsu Limited
  • ELC Group
  • Ergomed
  • iGATE Corporation
  • iMED Global Corporation
  • IQVIA
  • MarksMan Healthcare
  • Medpace Holdings
  • Oracle Corporation
  • Parexel
  • PharmInvent
  • PrimeVigilance
  • Pure Drug Safety
  • Sciformix
  • SIRO Clinpharm
  • Symogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  8. 1.5.1 North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (2021-2032)
2 Pharmacovigilance (PV) Outsourcing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Contract Research Organizations (CROs)
  3. 2.1.2 Business Process Outsourcing (BPOs)
  4. 2.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Type
  5. 2.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Pharmacovigilance (PV) Outsourcing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Pharmacovigilance (PV) Outsourcing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Pharmacovigilance (PV) Outsourcing Market Size by Regions
  9. 2.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Type (2021-2026)
3 Pharmacovigilance (PV) Outsourcing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Premarketing Clinical Trial
  3. 3.1.2 Post-marketing Clinical Practice
  4. 3.1.3 Other
  5. 3.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Application
  6. 3.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pharmacovigilance (PV) Outsourcing Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pharmacovigilance (PV) Outsourcing Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pharmacovigilance (PV) Outsourcing Market Size by Regions
  10. 3.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmacovigilance (PV) Outsourcing Industry Trends
  2. 4.2 Pharmacovigilance (PV) Outsourcing Industry Drivers
  3. 4.3 Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges
  4. 4.4 Pharmacovigilance (PV) Outsourcing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmacovigilance (PV) Outsourcing Revenue (2021-2026)
  2. 5.2 Global Pharmacovigilance (PV) Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmacovigilance (PV) Outsourcing Key Company Headquarters & Area Served
  4. 5.4 Global Pharmacovigilance (PV) Outsourcing Company, Product Type & Application
  5. 5.5 Global Pharmacovigilance (PV) Outsourcing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmacovigilance (PV) Outsourcing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmacovigilance (PV) Outsourcing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmacovigilance (PV) Outsourcing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Accenture
  2. 6.1.1 Accenture Company Information
  3. 6.1.2 Accenture Business Overview
  4. 6.1.3 Accenture Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
  6. 6.1.5 Accenture Recent Developments
  7. 6.2 C3i Solutions
  8. 6.2.1 C3i Solutions Company Information
  9. 6.2.2 C3i Solutions Business Overview
  10. 6.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
  12. 6.2.5 C3i Solutions Recent Developments
  13. 6.3 Clintec
  14. 6.3.1 Clintec Company Information
  15. 6.3.2 Clintec Business Overview
  16. 6.3.3 Clintec Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
  18. 6.3.5 Clintec Recent Developments
  19. 6.4 Covance
  20. 6.4.1 Covance Company Information
  21. 6.4.2 Covance Business Overview
  22. 6.4.3 Covance Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
  24. 6.4.5 Covance Recent Developments
  25. 6.5 Deloitte Touche Tohmatsu Limited
  26. 6.5.1 Deloitte Touche Tohmatsu Limited Company Information
  27. 6.5.2 Deloitte Touche Tohmatsu Limited Business Overview
  28. 6.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
  30. 6.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
  31. 6.6 ELC Group
  32. 6.6.1 ELC Group Company Information
  33. 6.6.2 ELC Group Business Overview
  34. 6.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
  36. 6.6.5 ELC Group Recent Developments
  37. 6.7 Ergomed
  38. 6.7.1 Ergomed Company Information
  39. 6.7.2 Ergomed Business Overview
  40. 6.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
  42. 6.7.5 Ergomed Recent Developments
  43. 6.8 iGATE Corporation
  44. 6.8.1 iGATE Corporation Company Information
  45. 6.8.2 iGATE Corporation Business Overview
  46. 6.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  48. 6.8.5 iGATE Corporation Recent Developments
  49. 6.9 iMED Global Corporation
  50. 6.9.1 iMED Global Corporation Company Information
  51. 6.9.2 iMED Global Corporation Business Overview
  52. 6.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  54. 6.9.5 iMED Global Corporation Recent Developments
  55. 6.10 IQVIA
  56. 6.10.1 IQVIA Company Information
  57. 6.10.2 IQVIA Business Overview
  58. 6.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
  60. 6.10.5 IQVIA Recent Developments
  61. 6.11 MarksMan Healthcare
  62. 6.11.1 MarksMan Healthcare Company Information
  63. 6.11.2 MarksMan Healthcare Business Overview
  64. 6.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
  66. 6.11.5 MarksMan Healthcare Recent Developments
  67. 6.12 Medpace Holdings
  68. 6.12.1 Medpace Holdings Company Information
  69. 6.12.2 Medpace Holdings Business Overview
  70. 6.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
  72. 6.12.5 Medpace Holdings Recent Developments
  73. 6.13 Oracle Corporation
  74. 6.13.1 Oracle Corporation Company Information
  75. 6.13.2 Oracle Corporation Business Overview
  76. 6.13.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  78. 6.13.5 Oracle Corporation Recent Developments
  79. 6.14 Parexel
  80. 6.14.1 Parexel Company Information
  81. 6.14.2 Parexel Business Overview
  82. 6.14.3 Parexel Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
  84. 6.14.5 Parexel Recent Developments
  85. 6.15 PharmInvent
  86. 6.15.1 PharmInvent Company Information
  87. 6.15.2 PharmInvent Business Overview
  88. 6.15.3 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
  90. 6.15.5 PharmInvent Recent Developments
  91. 6.16 PrimeVigilance
  92. 6.16.1 PrimeVigilance Company Information
  93. 6.16.2 PrimeVigilance Business Overview
  94. 6.16.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
  96. 6.16.5 PrimeVigilance Recent Developments
  97. 6.17 Pure Drug Safety
  98. 6.17.1 Pure Drug Safety Company Information
  99. 6.17.2 Pure Drug Safety Business Overview
  100. 6.17.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
  102. 6.17.5 Pure Drug Safety Recent Developments
  103. 6.18 Sciformix
  104. 6.18.1 Sciformix Company Information
  105. 6.18.2 Sciformix Business Overview
  106. 6.18.3 Sciformix Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
  108. 6.18.5 Sciformix Recent Developments
  109. 6.19 SIRO Clinpharm
  110. 6.19.1 SIRO Clinpharm Company Information
  111. 6.19.2 SIRO Clinpharm Business Overview
  112. 6.19.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
  114. 6.19.5 SIRO Clinpharm Recent Developments
  115. 6.20 Symogen
  116. 6.20.1 Symogen Company Information
  117. 6.20.2 Symogen Business Overview
  118. 6.20.3 Symogen Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
  120. 6.20.5 Symogen Recent Developments
  121. 6.21 Novartis
  122. 6.21.1 Novartis Company Information
  123. 6.21.2 Novartis Business Overview
  124. 6.21.3 Novartis Pharmacovigilance (PV) Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
  126. 6.21.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  3. 7.3 North America Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  3. 10.3 South America Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst